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Abstract
Background: The mortality rate of colorectal cancer ranks third behind lung and hepatic cancer in Taiwan.
Colorectal cancer mostly arises from adenomatous polyps of left colon. The aim of our study was to examine the
association of serum lipids with the histological pattern of rectosigmoid adenoma.
Methods: There were 2,506 eligible examinees aged 20 and above who underwent sigmoidoscopy as a screening
examination in National Cheng Kung University Hospital between January 2003 and October 2006. They were
classified into three groups: tubular adenoma (333 subjects), villous-rich (tubulovillous/villous) adenoma (53
subjects) and normal (2,120 subjects). We defined high total cholesterol (TC) as a level ≧200 mg/dl, low high-
density lipoprotein cholesterol (HDL-C) as a level <40 mg/dL, and high triglyceride (TG) as a level ≧200 mg/dl
according to the third report of the National Cholesterol Education Program expert panel on detection, evaluation,
and treatment of high blood cholesterol in adults. Adenoma histology was classified as tubular, tubulovillous and
villous according to the proportion of villous part.
Results: Among the study population, 333 subjects (13.3%) had tubular adenomas and 53 subjects (2.1%) had
villous-rich adenomas. The odds ratio (OR) for villous-rich adenoma in subjects with TG≧200 mg/dL compared to
those with TG < 200 mg/dL was 3.20 (95% confidence interval [CI]:1.71-6.01), after adjusting for age, gender,
general obesity, central obesity, diabetes, hypertension, smoking, and alcohol consumption. If further taking high
TC and low HDL-C into consideration, the OR was 4.42 (95% CI:2.03-9.63).
Conclusions: Our study showed that subjects with high serum TG tended to have a higher risk of tubulovillous/
villous adenoma in rectosigmoid colon. Therefore, reducing the serum TG level might be one method to prevent
the incidence of colorectal cancer.
Background
According to a report of the World Health Organiza-
tion, cancer was the leading cause of death in 2007,
accounting for 7.9 million deaths, or 13% of the total
amount. The same report stated that colorectal cancer
was the fourth most common fatal cancer, after lung,
stomach, and liver cancer [1]. In addition, the Depart-
ment of Health in Taiwan indicated that cancer was the
major cause of death from 1986 to 2008, with colorectal
cancer ranking third, after lung and liver cancer [2].
Seventy percent of colorectal cancer cases occur in the
left colon, including rectum, sigmoid and partial des-
cending colon [3], and colorectal cancer usually devel-
ops from colorectal polyps, especially adenomatous
polyps [4]. According to histological patterns, adenoma
types are classified into tubular, tubulovillous, and vil-
lous, with tubular adenoma being the most common,
and villous adenoma being the least. Tubular adenoma
has a 4% risk of developing malignancy, while tubulovil-
lous and villous adenomas may have risks up to 40% [5]. * Correspondence: yiching@mail.ncku.edu.tw
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influencing colorectal adenoma and its histology.
Previous studies on the relationship between serum
lipids and colorectal adenoma show conflicting results.
Serum triglyceride [6-9] and cholesterol [10-12] level are
positively related to an increased risk of colorectal ade-
noma in some studies, while several investigators report
an insignificant or even inverse relationship between
serum lipids and colorectal adenoma [13-15]. These
inconsistent results might be partially due to the asso-
ciation of serum lipids with different histological types
of colorectal adenoma, although such topic has received
little attention [16,17]. Therefore, we examined the asso-
ciation of serum lipids with the histology of rectosig-
moid adenoma, hoping to provide useful information for
preventing colorectal cancer.
Methods
Subjects
This is a retrospective research in which study subjects
were selected from 4,844 examinees aged 20 or above
who finished a health checkup with sigmoidoscopy as a
screening examination at the health promotion center of
National Cheng Kung University Hospital between Janu-
ary 2003 and October 2006. We excluded subjects with
the following conditions: using medication for hyperlipi-
demia; past history of cancer, inflammatory bowel dis-
ease, familial adenomatous polyposis or thyroid disease;
major gastrointestinal surgery, including partial or total
gastrectomy or colorectomy; colon cancer diagnosed
during sigmoidoscopic examination; vegetarian; dieting;
liver cirrhosis or SGPT levels three times higher than
the normal limit; nephrotic syndrome or serum creati-
nine levels higher than 1.5 mg/dL; CEA levels higher
than 10 ng/mL; incomplete examination and missing
data. Finally, 2,506 eligible subjects were drawn from
the original examinees.
Study Design
Each examinee was interviewed and received physical
examination by family physicians, and also completed
a structured questionnaire. The questionnaire gath-
ered basic personal information (age, gender, educa-
tion level, occupation, and marital status), personal
and family medical history (including details of hyper-
tension, diabetes mellitus, cardiovascular disease, cere-
brovascular disease, and cancer.), dietary habits, and
lifestyle (including cigarette smoking and alcohol
consumption).
The examinees fasted for at least eight hours, and also
stopped smoking, drinking alcohol, tea or coffee, and
taking personal medication. Intravenous blood was col-
lected and immediately sent to a central laboratory for
analysis of the complete blood count, lipid profile,
fasting glucose, uric acid, HbA1c, liver function test,
renal function test, electrolytes, and so on. All subjects,
except pregnant women or diabetic patients with oral
hypoglycemic agents or insulin injection, received a 75-
gram oral glucose tolerance test and were checked for
post-load two-hour blood glucose. Diabetes mellitus was
diagnosed according to the American Diabetes Associa-
tion diagnostic criteria [18]. Blood pressure was mea-
sured with a DIANAMP vital sign monitor [Model
1846SX DINAMAP Monitor, Critikon Inc., USA) after
five minutes of supine rest in a quiet examination room.
Hypertension was defined as a systolic blood pressure
(SBP)≧140 mmHg or diastolic blood pressure (DBP)≧90
mmHg according to the Seventh Report of the Joint
National Committee [19], or when the subjects had a
history of hypertension, or were receiving antihyperten-
sive treatment.
Total cholesterol and triglyceride levels were measured
by an enzymatic colorimetric test, and high density lipo-
protein cholesterol was measured by a direct method in
an automatic biochemical analyzer (Model 7600, Hoff-
mann-La Roche Inc., USA). According to the third
report of the National Cholesterol Education Program
expert panel on detection, evaluation and treatment of
high blood cholesterol in adults (NCEP-ATP III), total
cholesterol (TC) ≧240 mg/dL was defined as high, high-
density lipoprotein cholesterol (HDL-C) levels <40 mg/
dL as low and triglyceride (TG) levels ≧200 mg/dL as
high [20].
Anthropometric measurements were performed by
well-trained technicians and nurses. Body weight and
height were measured with an electronic scale (Model
HM-586, Jeng Jyi Co. Ltd, TAIWAN). Body mass index
(BMI) was calculated with weight (in kilograms) divided
by height (in meters) squared. Waist circumference was
measured at the level of the umbilicus and hip circum-
ference at the largest circumference over the buttocks
with a tape measure while standing relaxed. BMI≧25 kg/
m
2 is defined as general obesity and waist circumference
≥90 cm in men or ≥80 cm in women is defined as
abdominal obesity, according to Asia-Pacific criteria of
World Health Organization [21].
Experienced gastroenterologists used flexible sigmoid-
scopes (Model ES-200ER Fujinon Inc., JAPAN) to exam-
ine all subjects at least 60 centimeters from the anus.
When polyps were found in the colon or rectum, a
biopsy was conducted and sent to experienced patholo-
gists for interpretation. Colorectal adenomas were classi-
fied into three subtypes according to the percentage of
tubular vs. villous architecture. Specifically, tubular ade-
nomas exhibit more than 75% tubular architecture, vil-
lous adenomas have more than 50% of villous
architecture, and tubulovillous adenomas contain 25 to
50% villous architecture [22].
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We used SPSS statistical software version 12.0 for data
analyses. Study subjects were first classified into two
groups: normal and adenoma. The later was further
classified into tubular adenomas and villous-rich (tubu-
lovillous/villous) adenoma. Group differences for contin-
uous variables were assessed by independent t-test or
one way ANOVA, and the Chi-square test was used for
categorical variables. Multinomial logistic regression was
performed to calculate the odds ratio (OR) and 95%
confidence interval (CI) of lipid profiles on the risk of
tubular adenoma and villous-rich adenoma. We adjusted
for age and gender in Model 1, and further adjusted for
general obesity, abdominal obesity, diabetes, hyperten-
sion, smoking, and alcohol consumption in Model 2.
Finally, high TC, high TG and low HDL-C were further
added in Model 3. A p value < 0.05 was selected for sta-
tistical significance.
All authors declare that this research has followed all
applicable institutional and governmental regulations
concerning ethics and has been approved by the Institu-
tional Review Board of National Cheng Kung University
Hospital in Taiwan.
Results
A total of 2,506 subjects were used in the analysis.
There were 995 women (39.7%) and 1,511 men (60.3%)
with a mean age of 50.6 ± 12.4 (20.2-88.6 years).
Among the study population, 333 subjects (13.3%) had
tubular adenomas and 53 subjects (2.1%) had villous-
rich adenomas. Table 1 shows demographic and clinical
characteristics of normal and adenoma groups. Ade-
noma group was older, and had higher fasting glucose,
TC, TG and blood pressure, and lower HDL-C levels
than normal subjects. Male gender, diabetes, hyperten-
sion, general obesity, abdominal obesity, smoking, and
alcohol consumption were also more common in ade-
noma group.
Table 2 shows demographic and clinical characteristics
of normal, tubular, villous-rich adenoma groups. All
variables including age, BMI, waist circumference, fast-
i n gg l u c o s e ,T C ,T G ,H D L - C ,S B P ,D B P ,a n dt h ep r o -
portion of males, general obesity, abdominal obesity,
diabetes, hypertension, smoking and alcohol consump-
tion showed significant differences among the three
subgroups.
Figure 1 demonstrates the proportion of lipid abnorm-
alities according to ATP III criteria among the three
subgroups. There were significantly statistical differences
among the three subgroups with regard to high TC (P =
0.007) and high TG (P < 0.001), but not with regard to
low HDL-C (P = 0.118).
Table 3 shows the results of multinomial logistic
regression analyses, and the OR and 95% CI of lipid
profile for the risk of tubular adenoma and villous-rich
adenoma. In Model 1, with adjustment for age and gen-
der, high TC was related to both tubular (OR = 1.58,
95%CI: 1.08-2.32) and villous-rich adenoma (OR = 2.29,
95%CI: 1.05-5.01), and high TG was associated with the
risk of villous-rich adenoma (OR = 3.35, 95%CI: 1.87-
6.00), but not with tubular adenoma (OR = 1.35, 95%CI:
0.99-1.84). Further adjustment for general obesity,
abdominal obesity, diabetes, hypertension, smoking, and
alcohol consumption found that only high TG was asso-
ciated with the risk of villous-rich adenoma (OR = 3.20,
95%CI: 1.71-6.01)(Model 2). Moreover, when taking the
three lipid profiles into consideration together, high TG
was still an independent correlation factor of villous-
rich adenoma (OR = 4.42, 95%CI: 2.03-9.63) (Model 3).
In further analyses of different gender, with adjust-
ment for the same variables in Model 3, high TG was
highly related to villous-rich adenoma in women (OR =
17.27, 95%CI: 4.40-67.75). There was a trend toward vil-
lous-rich adenoma in men with high TG (OR = 2.50,
95%CI: 0.90-6.96), although not reaching statistical sig-
nificance (p = 0.078). In addition, when analyzing by age
strata, with adjustment for the same variables in Model
3, high TG was related to villous-rich adenoma in both
older subjects (OR = 4.03, 95%CI: 1.68-9.66) and in
younger subjects (OR = 5.24, 95%CI: 0.95-28.90),
although the later showed marginal statistical signifi-
cance (p = 0.057) (tables not showed).
Table 1 Comparisons of demographic and clinical
characteristics between normal and adenoma groups
Variables Normal
(n = 2120)
Adenoma
(n = 386)
P * value
Age (years) 49.6 ± 12.4 56.0 ±10.8 <0.001
Male, N (%) 1239 (58.4%) 272(70.5%) <0.001
BMI (kg/m
2) 24.5 ± 3.4 25.2 ±3.4 <0.001
WC (cm) 84.3 ± 10.4 87.5 ±10.4 <0.001
Fasting glucose (mg/dL) 93.3 ± 22.8 100.9 ±28.3 <0.001
Total cholesterol (mg/dL) 194.7 ± 36.9 200.3 ±38.5 0.007
Triglyceride(mg/dL) 129.4 ± 79.2 146.0 ±83.7 <0.001
HDL-C (mg/dL) 45.5 ± 11.8 43.7 ±11.8 0.005
SBP (mmHg) 117.4 ± 20.4 122.6 ±17.2 <0.001
DBP (mmHg) 68.8 ± 13.9 72.0 ±10.0 <0.001
General obesity
‡, N (%) 869 (41.0%) 194(50.3%) 0.001
Abdominal obesity
§, N (%) 894 (42.2%) 202(52.3%) <0.001
Hypertension, N (%) 478 (22.5%) 124(32.1%) <0.001
Diabetes mellitus, N (%) 304 (14.3%) 99(25.6%) <0.001
Smoking, N (%) 616 (29.1%) 144(37.3%) 0.001
Alcohol consumption, N (%) 489 (23.1%) 139(36.0%) <0.001
‡General obesity: BMI≧25 kg/m
2.
§Abdominal obesity: waist circumference of
men ≧90 cm or waist circumference of women ≧80 cm*P value of
independent t-test or Chi-square test. BMI, body mass index. WC, waist
circumference. HDL-C, high density lipoprotein cholesterol. SBP, systolic blood
pressure. DBP, diastolic blood pressure.
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adenoma, we did not perform detailed cross-tabulated
analyses of age and gender.
Discussion
Our study showed that subjects with adenoma had
higher TC and TG, and lower HDL-C levels than nor-
mal subjects. After considering more confounding fac-
tors, including not only age and gender, but also total
cholesterol, HDL-C, general obesity, abdominal obesity,
hypertension, diabetes, smoking, and alcohol consump-
tion, only high TG was associated with the risk of tubu-
lovillous/villous adenoma in rectosigmoid colon. We
found that subjects with adenoma were older, and had
higher fasting glucose and blood pressure than normal
subjects. Male gender, diabetes, hypertension, general
obesity, abdominal obesity, smoking, and alcohol con-
sumption were also more common in those with ade-
noma. As described in previous studies, the older
subjects had a higher risk of adenoma [23-27]. It has
Table 2 Comparisons of demographic and clinical characteristics between normal, tubular, villous-rich
† adenoma
groups
Variables Normal (n = 2120) Tubular adenoma (n = 333) Villous-rich
†adenoma (n = 53) P * value
Age (years) 49.6 ± 12.4 55.5 ± 10.7 59.3 ± 11.3 <0.001
Male, N (%) 1239 (58.4%) 233 (70.0%) 39 (73.6%) <0.001
BMI (kg/m
2) 24.5 ± 3.4 25.2 ± 3.4 25.6 ± 3.7 0.016
WC (cm) 84.3 ± 10.4 87.3 ± 10.3 88.6 ± 11.0 <0.001
Fasting glucose (mg/dL) 93.3 ± 22.8 99.6 ± 27.2 109.1 ± 33.6 <0.001
Total cholesterol (mg/dL) 194.7 ± 36.9 199.9 ± 38.9 202.4 ± 36.4 0.024
Triglyceride(mg/dL) 129.4 ± 79.2 143.3 ± 81.6 163.2 ± 94.7 <0.001
HDL-C (mg/dL) 45.5 ± 11.8 43.9 ± 11.7 42.4 ± 12.0 0.012
SBP (mmHg) 117.4 ± 20.4 121.3 ± 16.6 130.9 ± 18.6 <0.001
DBP (mmHg) 68.8 ± 13.9 71.6 ± 9.7 74.2 ± 11.4 <0.001
General obesity
‡, N (%) 869 (41.0%) 167 (50.2%) 27 (50.9%) 0.003
Abdominal obesity
§, N (%) 894 (42.2%) 175 (52.6%) 27 (50.9%) 0.001
Hypertension, N (%) 478 (22.5%) 97 (29.1%) 27 (50.9%) <0.001
Diabetes mellitus, N (%) 304 (14.3%) 80 (24.0%) 19 (35.8%) <0.001
Smoking, N (%) 616 (29.1%) 125 (37.5%) 19 (35.8%) 0.005
Alcohol consumption, N (%) 489 (23.1%) 124 (37.2%) 15 (28.3%) <0.001
†Villous-rich: tubulovillous and villous.
‡General obesity: BMI ≧25 kg/m
2.
§Abdominal obesity: waist circumference of men ≧90 cm or waist circumference of
women ≧80 cm*P value of ANOVA or Chi-square test. BMI, body mass index. WC, waist circumference. HDL-C, high density lipoprotein cholesterol. SBP, systolic
blood pressure. DBP, diastolic blood pressure.
Figure 1 Comparisons of lipid abnormality
† percentage between normal, tubular, villous-rich
‡ adenoma groups.¥
† Lipid abnormality:
TC ≧240 mg/dL, TG ≧200 mg/dL, HDL-C < 40 mg/dL.
‡Villous-rich: tubulovillous and villous. *P value of Chi-square test. TC, total cholesterol. TG,
triglyceride. HDL-C, high density lipoprotein cholesterol.
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age and appear in adenoma, the precursor of colorectal
cancer [4], but the mechanism for this still needs to be
clarified in future research. With regard to gender dif-
ferences, McCashland et al. suggested that estrogen may
have a protective role in preventing adenoma formation
via several mechanisms, such as estrogen receptor
genes, decreased secondary bile acid, and decreased
serum levels of insulin-like growth factors [28]. There-
fore, men have a higher prevalence of colon polyps than
women. On the other hand, diabetes [29,30], hyperten-
sion [31,32], general obesity [33,34], central obesity
[35,36] are more common in subjects with adenoma.
Insulin resistance or hyperinsulinemia might play an
important role in the development of adenoma
[24,29-36]. In addition, cigarette smoking has been con-
sistently associated with a higher risk of colorectal ade-
noma [37,38] and a positive association of alcohol use
with colorectal adenoma was found in some studies
[39-41], but not in others [42,43]. Our study showed
both smoking and alcohol consumption were positively
correlated with the risk of rectosigmoid adenoma. The
mechanisms are still not well understood, but carcino-
gens which are formed during the combustion of cigar-
ettes seem likely to be involved in smoking’s effect on
adenoma.
The effect of serum lipids on colorectal adenoma was
inconclusive in previous studies because of different
methodologies and inadequate sample sizes [6-15].
Moreover, different cut-points of serum lipids were used
in some studies, but we adopted the widely used ATP
III criteria for our analysis. Subjects with adenoma had
more lipid abnormalities th a nn o r m a ls u b j e c t si no u r
research. In Taiwan, there were studies showing that
low HDL-C and high TG in metabolic syndrome are
associated with increased risk for colorectal adenoma
[31,44]. However, they weren’t aimed at the histological
patterns of adenoma. Our study further investigated the
association of serum lipids with different histological
patterns of adenoma. Relatively few studies have
attempted this in the past. Houghton et al. investigated
158 patients; among them, one in 10 (9.5%, 15/158) of
subjects has polyps of villous histology. They found that
cholesterol levels were positively associated with a
greater likelihood of villous histology (OR, 1.18; 95%CI,
1.02-1.37) [17]. However, the significantly positive asso-
ciation between TC and villous adenoma disappeared
after further adjusting for TG and HDL in our study.
Another study by Tabuchi et al. performed a large scale
retrospective study with 4,887 patients to analyze the
correlation between the incidence of colorectal adenoma
and serum levels of TC and TG. Multiple logistic
regression analysis with adjustment for age and gender
revealed that TG was an independent correlation factor
in males with tubular adenoma, but not with villous
adenoma [16]. Consequently, our adjusted models con-
sidered more confounding factors than Tabuchi’s. The
association of high TG with tubular adenoma was lost
in our study; instead, its association with the risk of
tubulovillous/villous adenoma appeared. One possible
explanation is that, different to the previous studies, we
had fewer subjects with pure villous adenoma and we
Table 3 Multinomial logistic regression analysis for tubular adenoma and villous-rich
† adenoma in relation to lipid
abnormalities
Lipid abnormality Model 1
‡ Model 2
§ Model 3
¶
Tubular Villous-rich Tubular Villous-rich Tubular Villous-rich
Total cholesterol
<240 mg/dL 1.00 1.00 1.00 1.00 1.00 1.00
≧240 mg/dL 1.58 2.29 1.44 1.93 1.54 0.63
95% CI (1.08-2.32) (1.05-5.01) (0.97-2.13) (0.86-4.35) (0.83-2.84) (0.23-1.69)
P value 0.019 0.038 0.074 0.111 0.168 0.356
Triglyceride
<200 mg/dL 1.00 1.00 1.00 1.00 1.00 1.00
≧200 mg/dL 1.30 3.42 1.20 3.20 0.91 4.42
95% CI (0.94-1.78) (1.89-6.21) (0.86-1.67) (1.71-6.01) (0.54-1.53) (2.03-9.63)
P value 0.108 <0.001 0.278 <0.001 0.733 <0.001
HDL-C
≧40 mg/dL 1.00 1.00 1.00 1.00 1.00 1.00
<40 mg/dL 1.10 1.04 1.08 0.92 1.04 0.72
95% CI (0.86-1.42) (0.58-1.86) (0.83-1.40) (0.50-1.67) (0.80-1.36) (0.38-1.34)
P value 0.453 0.889 0.573 0.774 0.769 0.301
†Villous-rich: tubulovillous and villous.
‡Model 1: multivariate odds ratio adjusted for age and gender.
§Model 2: multivariate odds ratio adjusted for age, gender,
general obesity, abdominal obesity, hypertension, diabetes, smoking, and alcohol consumption.
¶Model 3: multivariate odds ratio adjusted for total cholesterol,
triglyceride, HDL-C, and all the variables in Model 2. HDL-C, high density lipoprotein cholesterol. CI, confidence interval.
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founding factors were considered and entered into our
final regression analysis. On the other hand, we had
adopted ATP III criteria that were commonly used in
clinical practice but were unusually applied for analysis
i no t h e rs t u d i e s .T Ca n dH D L - Ch a dn oa s s o c i a t i o n
with tubular or tubulovillous/villous adenoma, similar to
the results of previous studies about cholesterol and
overall adenoma [6,13,15].
There are several possible mechanisms that might
explain our findings. First, hypertriglyceridemia is asso-
ciated with hyperinsulinemia and insulin resistance
[45-47]. Elevated insulin may inhibit apoptosis by
interacting with insulin-like growth factors-I receptor,
enhancing nuclear factor-B activation or decreasing
peroxisome proliferator-activated receptor-g activation
[24]. A lower rate of apoptosis in normal mucosa is an
early event in the carcinogenesis process, and this may
eventually develop into colorectal adenoma and even
colorectal cancer. Second, patients with cholestyramine
treatment and ileal exclusion suffer from the malab-
sorption of bile acids, which leads to a compensatory
increase in bile acid biosynthesis, causing an increase in
serum total triglycerides as a result of an increase in the
VLDL fraction [48,49]. Increased bile acids are secreted
into the bile and enter the intestine where they undergo
further biotransformations and become secondary bile
acids in the colon. Secondary bile acids are potent non-
substrate inhibitors of glutathione sulfotransferase activ-
ity which is involved in the detoxification of exogenous
carcinogens, and some of their potentially toxic biologi-
cal activities might lead to mutagenicity, transforming
activity, and DNA-strand breakage [50]. Deoxycholic
acid, a secondary bile acid, was found to stimulate color-
ectal epithelial proliferation and promote adenoma for-
mation [51]. As is well known, tubulovillous and villous
adenoma have a higher potential for malignancy, and
thus, we suggest that tubulovillous/villous adenoma
might be more deeply affected by the above mentioned
mechanisms.
There are several limitations to this study. First, it
only includes subjects with colorectal adenoma in the
rectosigmoid colon, not in all portions of the colon. In
addition, the study’s populations were all Taiwanese,
and the findings might not be generalisable to other eth-
nic groups. Finally, our study is a cross-sectional one,
and thus cannot provide enough temporal evidence of a
causal relationship between serum lipids and the histo-
logical pattern of rectosigmoid adenoma. The strengths
of the study, however, are that we strictly controlled var-
ious confounding factors to reveal the actual correlation,
and adopted common ATP III criteria for analysis of
serum lipids to provide practical information for pri-
mary care physicians.
Conclusions
In our study, high serum triglyceride seems to be a
strong independent correlation factor with tubulovillous
and villous adenoma in the rectosigmoid colon. As a
consequence, to encourage patients with hypertriglyceri-
demia to reduce their serum triglyceride level seems to
be able to lower the risk of tubulovillous and villous
adenoma in the colorectum, and thus might be one
method to reduce the incidence of colorectal cancer.
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